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ABSTRACT
Several phospholipase A2 (PLA2) neurotoxins from snake venoms can affect acetylcholine release at the neu-
romuscular junction. In isolated nerve-muscle preparations three distinct phases have been described for this 
phenomenon: An initial transient decrease in twitch tension; a second facilitatory phase during which twitch 
height is greater than control twitch height; and the last phase which causes a reduction in twitch height that 
ﬁ  nally results in paralysis. Suramin has been reported to inhibit the toxic effects of β-bungarotoxin and another 
PLA2 neurotoxin, crotoxin in vitro and in vivo. We have further examined the effects of suramin on the three 
phases of the effects of the presynaptic PLA2 neurotoxins β-bungarotoxin, taipoxin and ammodytoxin on mouse 
phrenic nerve-hemidiaphragm preparations. When preparations were pre-treated with suramin (0.3mM), the early 
biphasic effects (depression followed by facilitation) were abolished, and the time taken for ﬁ  nal blockade induced 
by β-bungarotoxin, taipoxin and ammodytoxin A was signiﬁ  cantly prolonged. In contrast, suramin did not sig-
niﬁ  cantly affect the facilitation induced by the potassium channel blocking toxin dendrotoxin I when applied 
under the same conditions. In addition, application of 0.3mM suramin did not prevent the facilitatory actions 
of 3,4-diaminopyridine (3,4-DAP) and tetraethylammonium chloride (TEA). Overall, the mechanism whereby 
suramin reduces the effects of PLA2 neurotoxins remains elusive. Since suramin reduces both enzyme-dependent 
and enzyme-independent effects of the toxins, suramin is not acting as a simple enzyme inhibitor. Furthermore, 
the observation that suramin does not affect actions of standard K+ channel blockers suggests that suramin does 
not stabilise nerve terminals.
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INTRODUCTION
Suramin (an anti-trypanosomiasis drug and antagonist of 
P2 purinoceptors; Hoyle et al, 1990) has been reported 
to reverse the blocking action of non-depolarizing relax-
ants such as tubocurarine and pancuronium on twitch ten-
sion of rat diaphragm. This effect has not been observed 
on the paralysis caused by a depolarizing relaxant agent 
such as suxamethonium (Henning et al, 1992). Also 
suramin has an inhibitory effect on nerve terminal Ca2+ 
currents recorded from mouse triangularis sterni prepara-
tions (Henning et al, 1996; Lin et al, 2000). In addition, it 
has been reported that suramin can prevent the inhibitory 
effects of neurotoxins which block P-type Ca2+ channels, 
ω-conotoxin MVIIC and ω-agatoxin IVA, but has no effect 
on the non-selective Ca2+ channel blocker, Cd2+, on nerve-
evoked muscle contractions of mouse diaphragm prepa-
rations (Lin et al, 2000). Suramin has also been shown 
to interfere with the pharmacological effects of some 
snake venoms and toxins, for example; the PLA2 activ-
ity of Bothrops jararacussu snake (Sifuentes et al, 2008), 
the myotoxic and paralyzing effect of bothropstoxin-I 
(Oliveira et al, 2003), and the pharmacology of some cro-
talid venoms (Arruda et al, 2002). ©The Author(s) | Journal of Venom Research | 2011 | Vol 2 | 6-10 | OPEN ACCESS  7
solution) of the following composition: NaCl 118.4mM; KCl 
4.7mM; NaHCO3 25mM; KH2PO4 1.2mM; MgSO4.7H2O 
1.4mM; CaCl2 2.5mM; glucose 11.1mM, pH 7.3-7.4 and 
bubbled with oxygen containing 5% carbon dioxide and 
maintained at 27oC or 37oC. Twitches were evoked by stimu-
lating the phrenic nerves via platinum ring electrodes (0.2Hz 
with square wave pulses of 0.1ms and sufﬁ  cient strength to 
elicit maximal contractions) and recorded isometrically using 
Grass Model 79 and Grass Model 7D polygraphs, and Grass 
Force-Displacement Transducers FT03. In order to reveal 
any facilitation of neuromuscular transmission in twitch ten-
sion experiments, preparations were partially paralysed (to 
15-20% of control) by either the addition of 9-10mM MgCl2 
applied directly into the organ bath or by using physiological 
salt solution containing low Ca2+ (0.27-0.45mM). In some 
experiments, to ensure that direct stimulation of the nerve-
muscle preparation did not contribute to the overall tension 
recorded, indirectly evoked twitches were blocked by add-
ing successively greater concentrations of Mg2+ or low Ca2+ 
(less than 0.2mM) to the tissue bath and then re-adjusted 
with required amount of Mg2+ or Ca2+ to stabilise the twitch 
at 20% of control.
RESULTS
Effect of suramin on phrenic nerve-hemidiaphragm 
preparations
In order to determine the effect of suramin on twitch tension in 
the absence of PLA2 toxins, we ﬁ  rst tested its effect on mouse 
phrenic nerve-hemidiaphragm preparations. The preparations 
were indirectly stimulated and partly paralysed with low Ca2+ 
or high Mg2+ at 27oC or 37oC. Under these conditions, suramin 
(0.3mM) blocked the twitches. The blocking effect of suramin 
appeared without any delay and was temperature-dependent. 
This effect was accelerated signiﬁ  cantly by increasing the tem-
perature from 27oC to 37oC. The time to block was 35 ±6.6min 
at 27oC (n = 3) and 13 ±3min at 37oC (n = 4) (Figure 1). 
Effect of suramin on the responses to PLA2 neurotoxins
To monitor any changes in the amplitude of twitch tension 
caused by the PLA2 neurotoxins, it was necessary to main-
tain the twitch height at a stable level of 20 to 30% of control 
twitch height in the presence of suramin. This was achieved 
by adding a few drops (<100µl) of normal Krebs solution 
Suramin has also been shown to inhibit the physiological 
activity β-bungarotoxin, both in vivo and in vitro (Lin-Shiau 
and Lin, 1999). Suramin signiﬁ  cantly delayed the time to 
paralysis induced by β-bungarotoxin in mice when admin-
istered intravenously 30min before toxin. Also, suramin 
at 0.3mM effectively delayed the neuromuscular blocking 
effect of β-bungarotoxin and crotoxin in mouse phrenic 
nerve-muscle preparations when applied 20 to 30min before, 
or after application of toxins. In contrast, suramin had no 
signiﬁ  cant effect on the blocking action of a postsynaptic 
neurotoxin,  α-bungarotoxin (Lin-Shiau and Lin, 1999). 
Recently, suramin was shown to antagonise the haematoxin 
action of Echis carinatus (Iran) snake venom, and signiﬁ  -
cantly delaying time to death of envenomed mice (Fathi 
et al, 2010). Suramin also has a neuroprotective effect 
against  β-bungarotoxin-induced cytotoxicity on cultured 
cerebellar granule neurons (Tseng and Lin-Shiau, 2003). 
In addition, suramin abolished the increase of frequency 
and amplitude of miniature end plate potentials (m.e.p.ps) 
induced by β-bungarotoxin (Lin-Shiau and Lin, 1999) and 
prolonged the time course of block of end plate potentials 
(e.p.ps) by β-bungarotoxin.
The purpose of the present study was to investigate the 
effects of suramin on a panel of prejunctionally active tox-
ins, particularly looking at the early phases of their effects 
which are believed to be independent of their enzymatic 
activity.
MATERIALS AND METHODS
Reagents and materials
β-Bungarotoxin (T-5644, Lots 124H40081, 33H40141 and 
68H4003) was supplied by Sigma Chemical Co Ltd (Poole, 
Dorset, England) and Latoxan, 20 Rue Leon Blum, 2600 
Valence-France. Taipoxin was a gift from Dr David Eaker 
(Biochemistry Department, Uppsala University, Sweden) 
and was also purchased from Latoxan. Dendrotoxin I (DpI) 
was purchased from Ventoxin (Frederick, MD, USA). Two 
PLA2 toxins from the long-nosed viper (Vipera ammodytes 
ammodytes), ammodytoxin A and C, were gifts from Dr Igor 
Krizaj (Department of Biochemistry and Molecular Biology, 
University of Ljubljana, Slovenia). Tetraethylammonium 
chloride (TEA) and 3,4-diaminopyridine (3,4-DAP) and 
materials required for making salt solutions were purchased 
from Sigma Chemical Co Ltd or Gibco BRL Life Technolo-
gies Ltd. Suramin (sodium salt) was obtained from Bayer 
(Leverkusen, Germany).
Twitch tension recording of mouse phrenic nerve-
hemidiaphragm preparations
Mouse  hemidiaphragms and their phrenic nerves were 
removed from male mice (Balb C strain, 20-25gm) killed 
by CO2, in compliance with UK Home Ofﬁ  ce guidelines, 
immediately before experiments and placed in a dish con-
taining physiological salt solution. The preparations were 
cleaned under the microscope of any connective tissue and 
the diaphragm was divided into two triangular or wedge-
shaped parts. Each preparation was attached along its origin 
at the rib margin to a special tissue holder. The preparations 
were mounted in 10ml organ baths, under a resting tension 
of approximately 1gm in a physiological salt solution (Krebs 
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Figure 1. Effect of suramin (0.3mM) on twitch tension of mouse 
hemi-diaphragm at 27°C (A) in low Ca2+ and (B) at 37°C, in high 
Mg2+ (9-11mM) Krebs solution. Preparations were stimulated 
indirectly at 0.2Hz with pulses of 0.1ms duration and voltage 
greater than required to produce the maximum response. ©The Author(s) | Journal of Venom Research | 2011 | Vol 2 | 6-10 | OPEN ACCESS  8
the time taken to achieve twitch block. Figures 2-4 show the 
effects of suramin on the triphasic actions of β-bungarotoxin 
(n = 3), taipoxin (n = 4) and ammodytoxin A (n = 3), respec-
tively.
Lack of effect of suramin on the facilitatory action of 
dendrotoxin I (DpI)
The effect of suramin on the facilitatory action of den-
drotoxin I (DpI) (1μg/ml = 0.14μM) was investigated. 
Under the same conditions used for β-bungarotoxin, 
taipoxin, and ammodytoxin, preparations were incubated 
with 0.3mM suramin for 15-20min before application of 
DpI. In the control experiments, the facilitatory action 
of this toxin appeared without delay and without initial 
depression, the amplitude of twitch height increasing to 
more than twice of that of the control twitch height 
(263 ±13%) (n = 3) (Figure 5). Similar effects of DpI were 
observed in the experiments in which suramin was applied 
to the organ bath (at 4-6min intervals) until twitch tension 
height stabilised at desired height. Under these conditions 
the interaction between suramin and toxins was examined.
Phospholipase A2 neurotoxins cause triphasic changes on 
twitch tension of phrenic nerve-hemidiaphragm prepara-
tions. In view of the reported reversal action of suramin on 
neuromuscular blockade induced by these toxins, the effect 
of suramin on the triphasic action of three presynaptic PLA2 
neurotoxins, β-bungarotoxin (3μg/ml = 0.15μM), taipoxin 
(1μg/ml = 20nM) and ammodytoxin A (10μg/ml = 0.2μM) 
was investigated. 
After partial paralysis of preparations by reducing the con-
centration of Ca2+ (0.27-0.45mM) or increasing the concen-
tration of Mg2+ (9-11mM), the preparations were pre-treated 
with 0.3mM suramin for 15-20min before application of 
toxins. Suramin abolished the early biphasic effects, i.e., 
depression and facilitation, and signiﬁ  cantly  prolonged 
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Figure 2. A. Effect of β-bungarotoxin (3μg/ml = 0.15μM) on 
twitch tension of mouse hemi-diaphragm partly paralysed by low 
Ca2+ Krebs solution. B. Effect of suramin (0.3mM) on triphasic 
action of β-bungarotoxin (3μg/ml = 0.15μM) when applied 20 min 
before application of toxin. Preparations were stimulated indirectly 
at 0.2Hz with pulses of 0.1ms duration and voltage greater than 
required to produce the maximum response.
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Figure 3. A. Effect of taipoxin (1μg/ml = 20nM) on twitch tension 
of mouse hemi-diaphragm partly paralysed by low Ca2+ Krebs 
solution. B. Effect of suramin (0.3mM) on the triphasic action of 
taipoxin (1μg/ml = 20nM) when applied 20 min before application 
of toxin. Preparations were stimulated indirectly at 0.2Hz with 
pulses of 0.1ms duration and voltage greater than required to 
produce the maximum response.
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Figure 4. A. Effect of ammodytoxin A (10μg/ml = 2μM) on 
twitch tension of mouse hemi-diaphragm partly paralysis by high 
Mg2+ (9-11mM) Krebs solution. B. Effect of suramin (0.3mM) on 
the triphasic action of ammodytoxin when applied 20 min before 
application of toxin. Preparations were stimulated indirectly at 
0.2Hz with pulses of 0.1ms duration and voltage greater than 
required to produce the maximum response.
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Figure 5. A. Effect of dendrotoxin I (DpI) (1μg/ml = 0.14 μM) 
on twitch tension of mouse hemi-diaphragm partly paralysed 
by high Mg2+ (9-11mM) Krebs solution. B. Lack of effect of 
suramin (0.3mM) on the facilitatory action of dendrotoxin I 
(DpI) (1μg/ml = 0.14μM) when applied 20min before application 
of toxin. Preparations were stimulated indirectly at 0.2Hz with 
pulses of 0.1ms duration and voltage greater than required 
to produce the maximum response.©The Author(s) | Journal of Venom Research | 2011 | Vol 2 | 6-10 | OPEN ACCESS  9
a block a fraction of the K+ current recorded as perineural 
waveforms from mouse triangularis sterni preparations 
(Rowan and Harvey, 1988; Krizaj et al, 1995; Lin-Shiau and 
Lin, 1999). As suramin did not affect the facilitatory action 
of K+ channel blockers, TEA, 3,4-DAP and dendrotoxin it 
is unlikely that the pharmacology of suramin is mediated 
through potassium channels. Suramin is a polysulfate ani-
onic compound rich in negative charges that can interact 
with positive charges on peptides and proteins, thus it is 
possible that suramin could directly bind with the PLA2 
toxin. This interaction would be predicted to cause a con-
formational change which may delay binding to acceptors 
on the nerve terminals. However, it is difﬁ  cult to explain 
the lack of effect of suramin on the neuromuscular blocking 
effect of a postsynaptic neurotoxin α-bungarotoxin or of the 
facilitatory toxin DpI, both of which also have positively 
charged residues. The mechanism of action of suramin at 
the neuromuscular junction is still not clear, although it was 
suggested that suramin inhibited Ca2+ entry to the nerve ter-
minal by binding weakly to presynaptic voltage-dependent 
Ca2+ channels and reducing the release of acetylcholine 
(Henning et al, 1996; Lin et al, 2000). Such a mode of 
action can explain the twitch blocking effect of suramin 
on mouse nerve-hemidiaphragms partially paralysed by 
low Ca2+ or high Mg2+ but cannot account for the antago-
nistic effect of suramin on the neuromuscular effects of 
β-bungarotoxin, as Cd2+, a Ca2+ channel blocker, does not 
alter the pharmacology of such toxins on neuromuscu-
lar transmission (Lin-Shiau and Lin, 1999). Overall, the 
mechanism whereby suramin reduces the effects of PLA2 
neurotoxins remains elusive. Since suramin reduces both 
enzyme-dependent and enzyme-independent effects of the 
toxins, suramin is not acting as a simple enzyme inhibitor. 
As suramin does not affect the actions of standard K+ chan-
nel blockers, it is not stabilising nerve terminals. Perhaps 
there is a direct physical interaction between suramin and 
the toxins as has been suggested to account for the effect 
of suramin on the myotoxic activity of Lys49 homologues 
(Murakami et al, 2007).
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